Holen Sie sich die Stockscreener-App
3.69
31.49%
0.88
Schlusskurs vom Vortag:
$2.81
Offen:
$3.59
24-Stunden-Volumen:
65.13M
Relative Volume:
29.85
Marktkapitalisierung:
$307.43M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-36.95M
KGV:
-4.3929
EPS:
-0.84
Netto-Cashflow:
$-33.46M
1W Leistung:
+21.95%
1M Leistung:
+0.14%
6M Leistung:
-5.50%
1J Leistung:
+21.95%
1-Tages-Spanne:
$3.55
$4.01
1-Wochen-Bereich:
$2.715
$4.01
52-Wochen-Spanne:
$1.61
$5.37
Larimar Therapeutics Inc Stock (LRMR) Company Profile
Firmenname
Larimar Therapeutics Inc
Sektor
Branche
Telefon
844-511-9056
Adresse
THREE BALA PLAZA EAST. SUITE 506, BALA CYNWYD, PA
Compare LRMR vs VRTX, REGN, ARGX, ALNY, ONC
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LRMR
Larimar Therapeutics Inc
|
3.70 | 233.48M | 0 | -36.95M | -33.46M | -0.84 |
|
VRTX
Vertex Pharmaceuticals Inc
|
488.92 | 122.19B | 12.07B | 3.95B | 3.19B | 15.33 |
|
REGN
Regeneron Pharmaceuticals Inc
|
777.73 | 83.21B | 14.34B | 4.50B | 3.77B | 41.56 |
|
ARGX
Argen X Se Adr
|
833.89 | 51.13B | 3.06B | 1.28B | 447.35M | 19.67 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.83 | 43.68B | 3.71B | 313.75M | 465.38M | 2.2571 |
|
ONC
Beone Medicines Ltd Adr
|
367.35 | 41.01B | 4.98B | 69.60M | 525.67M | 0.5198 |
Larimar Therapeutics Inc Stock (LRMR) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-29 | Eingeleitet | Truist | Buy |
| 2024-10-16 | Eingeleitet | Oppenheimer | Outperform |
| 2024-10-03 | Eingeleitet | Wedbush | Outperform |
| 2024-10-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2024-09-04 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-03 | Eingeleitet | Leerink Partners | Outperform |
| 2023-11-17 | Hochstufung | Citigroup | Neutral → Buy |
| 2022-10-19 | Eingeleitet | Guggenheim | Buy |
| 2022-02-15 | Herabstufung | William Blair | Outperform → Mkt Perform |
| 2021-02-10 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2021-02-01 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Larimar Therapeutics Inc Aktie (LRMR) Neueste Nachrichten
Biotech and Big Tech Drive the Morning Narrative - Investing News Network
Larimar Therapeutics (LRMR) Surges On FDA Breakthrough Therapy Designation - Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session - Benzinga
Larimar Soars After FDA Grants Breakthrough Therapy Status To Friedreich's Ataxia Candidate - Nasdaq
Larimar Therapeutics jumps on FDA Breakthrough Therapy Designation for nomlabofusp - Quiver Quantitative
Larimar Therapeutics stock surges on FDA breakthrough status By Investing.com - Investing.com South Africa
Larimar Therapeutics stock surges on FDA breakthrough status - Investing.com UK
Larimar Therapeutics’ Recent Stock Trends and Financial Insights - timothysykes.com
Larimar Therapeutics (LRMR) Surges on FDA Breakthrough Designati - GuruFocus
Why Did Larimar Therapeutics’ Stock Surge Over 30% Pre-Market Today? - Stocktwits
Larimar Therapeutics' Friedreich's Ataxia Therapy Receives FDA Breakthrough Status; Shares Rise - marketscreener.com
Larimar Therapeutics shares surged 35.6% in pre-market trading after the company announced that its treatment for a neurological disease had received “Breakthrough Therapy” designation from the U.S. Food and Drug Administration (FDA). - Bitget
Larimar surges on FDA breakthrough status for lead asset - Seeking Alpha
FDA Grants Breakthrough Therapy Status to Larimar’s Nomlabofusp - TipRanks
Larimar Therapeutics announces FDA Breakthrough Therapy Designation for nomlabofusp - marketscreener.com
Larimar Therapeutics wins FDA Breakthrough Therapy Designation for nomlabofusp; BLA on track for June 2026 - TradingView
Larimar Therapeutics Announces FDA Breakthrough Therapy Designation for Nomlabofusp in FA and Reiterates Planned BLA Submission in June 2026 - Yahoo Finance
IPO Launch: Can Larimar Therapeutics Inc beat the S P 500July 2025 Breakouts & Fast Moving Stock Trade Plans - baoquankhu1.vn
Forecast Cut: Is Larimar Therapeutics Inc being accumulated by smart moneyJuly 2025 Weekly Recap & Short-Term High Return Ideas - baoquankhu1.vn
Is Larimar Therapeutics Inc. impacted by rising ratesCEO Change & Detailed Earnings Play Strategies - mfd.ru
Does Larimar Therapeutics Inc. have consistent dividend growthDollar Strength & Daily Entry Point Trade Alerts - mfd.ru
Investor Mood: Is Larimar Therapeutics Incs growth already priced in2025 Market Trends & Free Expert Verified Stock Movement Alerts - baoquankhu1.vn
Is Larimar Therapeutics Inc. being accumulated by smart moneyQuarterly Portfolio Summary & Verified Technical Trade Signals - mfd.ru
Does Larimar Therapeutics Inc. have a sustainable dividendWeekly Investment Report & Smart Investment Allocation Insights - mfd.ru
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat
Gap Down: Will Larimar Therapeutics Inc benefit from geopolitical trendsJuly 2025 Drop Watch & Consistent Return Strategy Ideas - baoquankhu1.vn
Guidance Update: Does Larimar Therapeutics Inc have consistent dividend growthJuly 2025 Setups & Free AI Powered Buy and Sell Recommendations - baoquankhu1.vn
Geopolitics Watch: Is Larimar Therapeutics Inc. being accumulated by smart money2025 Price Momentum & AI Powered Buy/Sell Recommendations - baoquankhu1.vn
Portfolio Update: Is Smith Douglas Homes Corp a cyclical or defensive stockQuarterly Risk Review & Verified Short-Term Trading Plans - baoquankhu1.vn
Larimar Therapeutics executes strategic stock exchange agreement - MSN
Larimar’s Pediatric Friedreich’s Ataxia Trial Termination: What Investors Should Know - TipRanks
Friedreich's Ataxia Pipeline 2025: FDA Approvals and Clinical - openPR.com
AIGH Capital Management LLC Takes $3.23 Million Position in Larimar Therapeutics, Inc. $LRMR - MarketBeat
We Think Larimar Therapeutics (NASDAQ:LRMR) Needs To Drive Business Growth Carefully - Sahm
Head-To-Head Survey: Oncology Pharma (OTCMKTS:ONPH) vs. Larimar Therapeutics (NASDAQ:LRMR) - Defense World
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Average Rating of “Moderate Buy” from Analysts - Defense World
Larimar Therapeutics, Inc. (NASDAQ:LRMR) Receives Average Rating of "Moderate Buy" from Analysts - MarketBeat
Larimar Therapeutics: The Market Is Mispricing A Potential Standard Of Care (NASDAQ:LRMR) - Seeking Alpha
Aug Gainers: What risks investors should watch in Larimar Therapeutics Inc stockQuarterly Profit Summary & Low Risk Entry Point Guides - Bộ Nội Vụ
Published on: 2026-01-14 08:49:57 - Bộ Nội Vụ
Death Cross: How Larimar Therapeutics Inc stock performs during Fed tightening cyclesM&A Rumor & Risk Adjusted Buy and Sell Alerts - Bộ Nội Vụ
Published on: 2026-01-13 20:02:33 - Bộ Nội Vụ
Aug Intraday: Will Larimar Therapeutics Inc. stock outperform value stocks2025 Technical Patterns & Risk Adjusted Buy/Sell Alerts - Bộ Nội Vụ
Published on: 2026-01-13 12:38:02 - moha.gov.vn
Volatility Watch: Does Larimar Therapeutics Inc have a sustainable dividendTrade Risk Assessment & AI Forecast Swing Trade Picks - baoquankhu1.vn
Will Larimar Therapeutics Inc. stock outperform value stocksTrade Volume Summary & Pattern Based Trade Signal System - ulpravda.ru
Contact | Statesman-ExaminerLarimar Therapeutics, Inc.Common Stock (Nasdaq:LRMR) Detailed Stock Data - FinancialContent
Why Larimar Therapeutics Inc. stock remains resilientRate Cut & AI Powered Market Entry Strategies - Улправда
Larimar Therapeutics Advances Friedreich’s Ataxia Program with New Publications on Nomlabofusp Data - MSN
How Larimar Therapeutics Inc. (ZA71) stock trades after rate cutsMarket Volume Report & Low Risk Entry Point Tips - ulpravda.ru
Will Larimar Therapeutics Inc. (ZA71) stock see valuation expansionWeekly Gains Summary & Weekly Watchlist for Hot Stocks - Улправда
Finanzdaten der Larimar Therapeutics Inc-Aktie (LRMR)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.25%
0.73%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):